Democrats' policy package to include prescription drug cost controls and Obamacare fix
Reuters
Published Jul 19, 2022 03:12PM ET
Updated Jul 19, 2022 04:01PM ET
By Richard Cowan
WASHINGTON (Reuters) -U.S. Senate Majority Leader Chuck Schumer said on Tuesday that prescription drug cost controls and an Obamacare fix are the components Democrats will seek for now in a fast-track domestic policy bill.
"The two things we want to do in reconciliation, that we're going to do in reconciliation, are prescription drugs and a two-year extension of ACA," Schumer told reporters.
"ACA" refers to the Affordable Care Act, commonly known as Obamacare.
Democrats are seeking to keep in place increased financial assistance for people who qualify for subsidized health insurance under ACA. The premium relief was offered as part of the American Rescue Plan enacted in 2021, but is set to expire this year, which would result in stark premium increases for millions of people unless Congress acts.
The prescription drug plan would allow Medicare, the government's health plan for senior citizens and the disabled, to negotiate lower prices.
"Reconciliation" refers to an exclusive number of bills that can move through the Senate with a simple majority of support in the 100-member chamber, instead of the 60 votes usually needed.
So far, Schumer has failed to win the backing of Democratic Senator Joe Manchin for a major climate change initiative and tax increases on some corporations as part of such legislation. Without every one of his 50 Democratic caucus members, Schumer does not have the votes to pass bills given solid Republican opposition.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.